bibliographicCitation |
Chen Q, Han X, Zheng G, Yang Y, Li Y, Zhang E, Yang L, Dong M, He D, He J, Cai Z. The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China. Front Oncol. 2022;12():1084683. PMID: 36605445; PMCID: PMC9808074. |